VPS37A
Basic information
Region (hg38): 8:17246931-17302427
Previous symbols: [ "PQBP2" ]
Links
Phenotypes
GenCC
Source:
- hereditary spastic paraplegia 53 (Supportive), mode of inheritance: AR
- hereditary spastic paraplegia 53 (Limited), mode of inheritance: AR
- hereditary spastic paraplegia 53 (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Spastic paraplegia 53, autosomal recessive | AR | General | The use of botulinum has been described as beneficial for treating spasticity in some individuals, though the advantage of genetic diagnosis is unclear; Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 22717650 |
ClinVar
This is a list of variants' phenotypes submitted to
- Hereditary_spastic_paraplegia_53 (136 variants)
- not_specified (66 variants)
- not_provided (34 variants)
- Hereditary_spastic_paraplegia (16 variants)
- VPS37A-related_disorder (6 variants)
- Idiopathic_transverse_myelitis (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the VPS37A gene is commonly pathogenic or not. These statistics are base on transcript: NM_000152415.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 33 | 36 | ||||
missense | 107 | 114 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 3 | |||||
Total | 1 | 1 | 113 | 37 | 1 |
Highest pathogenic variant AF is 0.000262547
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
VPS37A | protein_coding | protein_coding | ENST00000324849 | 11 | 55857 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000679 | 0.996 | 125721 | 0 | 16 | 125737 | 0.0000636 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.885 | 235 | 200 | 1.18 | 0.00000897 | 2603 |
Missense in Polyphen | 37 | 48.493 | 0.76299 | 678 | ||
Synonymous | -1.82 | 92 | 72.3 | 1.27 | 0.00000352 | 731 |
Loss of Function | 2.53 | 9 | 21.7 | 0.414 | 0.00000102 | 276 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000150 | 0.000150 |
Ashkenazi Jewish | 0.000202 | 0.0000992 |
East Asian | 0.000110 | 0.000109 |
Finnish | 0.0000929 | 0.0000924 |
European (Non-Finnish) | 0.0000355 | 0.0000352 |
Middle Eastern | 0.000110 | 0.000109 |
South Asian | 0.000102 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the ESCRT-I complex, a regulator of vesicular trafficking process. Required for the sorting of endocytic ubiquitinated cargos into multivesicular bodies. May be involved in cell growth and differentiation. {ECO:0000269|PubMed:15240819}.;
- Pathway
- Endocytosis - Homo sapiens (human);Disease;Vesicle-mediated transport;Membrane Trafficking;Assembly Of The HIV Virion;Budding and maturation of HIV virion;Late Phase of HIV Life Cycle;HIV Life Cycle;HIV Infection;Endosomal Sorting Complex Required For Transport (ESCRT);Infectious disease;Membrane binding and targetting of GAG proteins;Synthesis And Processing Of GAG, GAGPOL Polyproteins
(Consensus)
Intolerance Scores
- loftool
- 0.592
- rvis_EVS
- -0.54
- rvis_percentile_EVS
- 20.54
Haploinsufficiency Scores
- pHI
- 0.130
- hipred
- Y
- hipred_score
- 0.825
- ghis
- 0.619
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.904
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Vps37a
- Phenotype
Zebrafish Information Network
- Gene name
- vps37a
- Affected structure
- whole organism
- Phenotype tag
- abnormal
- Phenotype quality
- decreased mobility
Gene ontology
- Biological process
- protein targeting to membrane;protein targeting to vacuole;protein transport;endosomal transport;macroautophagy;viral life cycle;endosome transport via multivesicular body sorting pathway;multivesicular body assembly;viral budding via host ESCRT complex;ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway
- Cellular component
- ESCRT I complex;nucleoplasm;centrosome;cytosol;endosome membrane;late endosome membrane;intracellular membrane-bounded organelle
- Molecular function
- protein binding